File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: preliminary results

TitleA randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: preliminary results
Authors
Issue Date2014
Citation
Clinical Ophthalmology, 2014, v. 8, p. 1987-1992 How to Cite?
AbstractBACKGROUND: The objective of this study was to investigate the effects of adjuvant selective laser trabeculoplasty (SLT) versus medication alone on intraocular pressure (IOP) control, medication use, and quality of life in patients with primary open-angle glaucoma. METHODS: This prospective, randomized control study recruited 41 consecutive primary open-angle glaucoma subjects with medically-controlled IOP /=0.4) or between the two treatment groups (P>/=0.2). CONCLUSION: A single session of adjuvant SLT provided further reductions in IOP and medication without substantial changes in quality of life or medication tolerability at 6 months.
Persistent Identifierhttp://hdl.handle.net/10722/208490
ISSN
2015 SCImago Journal Rankings: 0.787
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorLee, WYJen_US
dc.contributor.authorChan, CWen_US
dc.contributor.authorWong, MOen_US
dc.contributor.authorChan, JCHen_US
dc.contributor.authorLi, Qen_US
dc.contributor.authorLai, JSen_US
dc.date.accessioned2015-03-11T07:06:23Z-
dc.date.available2015-03-11T07:06:23Z-
dc.date.issued2014en_US
dc.identifier.citationClinical Ophthalmology, 2014, v. 8, p. 1987-1992en_US
dc.identifier.issn1177-5467en_US
dc.identifier.urihttp://hdl.handle.net/10722/208490-
dc.description.abstractBACKGROUND: The objective of this study was to investigate the effects of adjuvant selective laser trabeculoplasty (SLT) versus medication alone on intraocular pressure (IOP) control, medication use, and quality of life in patients with primary open-angle glaucoma. METHODS: This prospective, randomized control study recruited 41 consecutive primary open-angle glaucoma subjects with medically-controlled IOP </=21 mmHg. The SLT group (n=22) received a single 360-degree SLT treatment. The medication-only group (n=19) continued with their usual treatment regimen. In both groups, medication was titrated to maintain a target IOP defined as a 25% reduction from baseline IOP without medication, or <18 mmHg, whichever was lower. Outcomes, which were measured at baseline and at 6 months, included the Glaucoma Quality of Life-15 (GQL-15) and Comparison of Ophthalmic Medications for Tolerability (COMTOL) survey scores, IOP, and the number of antiglaucoma medicines. RESULTS: The baseline IOP was 15.8+/-2.7 mmHg and 14.5+/-2.5 mmHg in the SLT and medication-only groups, respectively (P=0.04). Both groups had a comparable number of baseline medication (P=0.2), GQL-15 (P=0.3) and COMTOL scores (P=0.7). At 6 months, the SLT group had a lower IOP (P=0.03) and required fewer medications compared with both baseline (P<0.0001) and with the medication-only group (P=0.02). There was no statistically significant difference in the 6-month GQL-15 or COMTOL score as compared to baseline (P>/=0.4) or between the two treatment groups (P>/=0.2). CONCLUSION: A single session of adjuvant SLT provided further reductions in IOP and medication without substantial changes in quality of life or medication tolerability at 6 months.en_US
dc.languageengen_US
dc.relation.ispartofClinical Ophthalmologyen_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleA randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: preliminary resultsen_US
dc.typeArticleen_US
dc.identifier.emailLee, WYJ: jackylee@hku.hken_US
dc.identifier.authorityLee, WYJ=rp01498en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.2147/OPTH.S70903en_US
dc.identifier.pmid25284983-
dc.identifier.pmcid4181747-
dc.identifier.scopuseid_2-s2.0-84907710042-
dc.identifier.hkuros264614-
dc.identifier.volume8en_US
dc.identifier.spage1987en_US
dc.identifier.epage1992en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats